Open Access
CC BY-NC-ND 4.0 · Endosc Int Open 2020; 08(06): E717-E721
DOI: 10.1055/a-1119-6698
Innovation forum

The band and slough technique is effective for management of diminutive type 1 gastric and duodenal neuroendocrine tumors

Authors

  • Fadi Hawa

    1   Department of Internal Medicine, St. Joseph Mercy Ann Arbor Hospital, Ypsilanti, Michigan, United States
  • Zeyad Sako

    2   Department of Hematology and Oncology, Ascension St. John Hospital, Detroit, Michigan, United States
  • Than Nguyen

    4   Department of Gastroenterology and Hepatology, Kaiser Permanente Vacaville Medical Center, Vacaville, California, United States
  • Andrew T. Catanzaro

    3   Department of Gastroenterology and Hepatology, Huron Gastroenterology Associates, St. Joseph Mercy Ann Arbor Hospital, Ypsilanti, Michigan, United States
  • Eugene Zolotarevsky

    5   Department of Gastroenterology and Hepatology, Spectrum Health Hospitals, Grand Rapids, Michigan, United States
  • Angela N. Bartley

    6   Department of Pathology, St. Joseph Mercy Ann Arbor Hospital, Ypsilanti, Michigan, United States
  • Naresh T. Gunaratnam

    3   Department of Gastroenterology and Hepatology, Huron Gastroenterology Associates, St. Joseph Mercy Ann Arbor Hospital, Ypsilanti, Michigan, United States

Abstract

Background and study aims Endoscopic resection is recommended as initial treatment for early-stage gastric and duodenal neuroendocrine tumors (G-NETs and D-NETs). However, it can cause serious adverse events. We aimed to evaluate the efficacy and safety of the band and slough (BAS) technique as a novel and less aggressive endoscopic therapy for management of such tumors.

Four patients, three diagnosed with < 10-mm D-NET and one with 10-mm type I G-NET, were treated with the BAS technique without endoscopic resection. Initial follow-up endoscopy at 3 months was done to assess for residual tumor. Subsequent endoscopic surveillance was performed. After one session of banding, all patients achieved complete remission at 3-month follow-up. No tumor recurrence was detected on repeat biopsy at 12-month surveillance endoscopy. None of the patients developed any adverse events including bleeding or perforation.

The BAS technique may prove to be a safe and effective endoscopic therapy for diminutive, non-metastatic type 1 G-NETs and D-NETs. Studies of larger scale and longer follow-up periods are needed to corroborate these findings.



Publication History

Received: 03 November 2019

Accepted: 03 February 2020

Article published online:
25 May 2020

© 2020. Owner and Copyright ©

© Georg Thieme Verlag KG
Stuttgart · New York